Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

Open access
Brueggemann, Angela B, Jansen van Rensburg, Melissa J, Shaw, David, McCarthy, Noel D, Jolley, Keith A, Maiden, Martin C J, van der Linden, Mark P G, Amin-Chowdhury, Zahin, Bennett, Désirée E, Borrow, Ray, Brandileone, Maria-Cristina C, Broughton, Karen, Campbell, Ruth, Cao, Bin, Casanova, Carlo, Choi, Eun Hwa, Chu, Yiu Wai, Clark, Stephen A, Claus, Heike, Coelho, Juliana, Corcoran, Mary, Cottrell, Simon, Cunney, Robert J, Dalby, Tine, Davies, Heather, de Gouveia, Linda, Deghmane, Ala-Eddine, Demczuk, Walter, Desmet, Stefanie, Drew, Richard J, du Plessis, Mignon, Erlendsdottir, Helga, Fry, Norman K, Fuursted, Kurt, Gray, Steve J, Henriques-Normark, Birgitta, Hale, Thomas, Hilty, Markus, Hoffmann, Steen, Humphreys, Hilary, Ip, Margaret, Jacobsson, Susanne, Johnston, Jillian, Kozakova, Jana, Kristinsson, Karl G, Krizova, Pavla, Kuch, Alicja, Ladhani, Shamez N, Lâm, Thiên-Trí, Lebedova, Vera, Lindholm, Laura, Litt, David J, Martin, Irene, Martiny, Delphine, Mattheus, Wesley, McElligott, Martha, Meehan, Mary, Meiring, Susan, Mölling, Paula, Morfeldt, Eva, Morgan, Julie, Mulhall, Robert M, Muñoz-Almagro, Carmen, Murdoch, David R, Murphy, Joy, Musilek, Martin, Mzabi, Alexandre, Perez-Argüello, Amaresh, Perrin, Monique, Perry, Malorie, Redin, Alba, Roberts, Richard, Roberts, Maria, Rokney, Assaf, Ron, Merav, Scott, Kevin J, Sheppard, Carmen L, Siira, Lotta, Skoczyńska, Anna, Sloan, Monica, Slotved, Hans-Christian, Smith, Andrew J, Song, Joon Young, Taha, Muhamed-Kheir, Toropainen, Maija, Tsang, Dominic, Vainio, Anni, van Sorge, Nina M, Varon, Emmanuelle, Vlach, Jiri, Vogel, Ulrich, Vohrnova, Sandra, von Gottberg, Anne, Zanella, Rosemeire C, Zhou, Fei · 2021 · The Lancet Digital Health

Published version of a preprint

Abstract

BACKGROUND: Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, which are typically transmitted via respiratory droplets, are leading causes of invasive diseases, including bacteraemic pneumonia and meningitis, and of secondary infections subsequent to post-viral respiratory disease. The aim of this study was to investigate the incidence of invasive disease due to these pathogens during the early months of the COVID-19 pandemic. METHODS: In this prospective analysis of surveillance data, laboratories in 26 countries and territories across six continents submitted data on cases of invasive disease due to S pneumoniae, H influenzae, and N meningitidis from Jan 1, 2018, to May, 31, 2020, as part of the Invasive Respiratory Infection Surveillance (IRIS) Initiative. Numbers of weekly cases in 2020 were compared with corresponding data for 2018 and 2019. Data for invasive disease due to Streptococcus agalactiae, a non-respiratory pathogen, were collected from nine laboratories for comparison. The stringency of COVID-19 containment measures was quantified using the Oxford COVID-19 Government Response Tracker. Changes in population movements were assessed using Google COVID-19 Community Mobility Reports. Interrupted time-series modelling quantified changes in the incidence of invasive disease due to S pneumoniae, H influenzae, and N meningitidis in 2020 relative to when containment measures were imposed. FINDINGS: 27 laboratories from 26 countries and territories submitted data to the IRIS Initiative for S pneumoniae (62 837 total cases), 24 laboratories from 24 countries submitted data for H influenzae (7796 total cases), and 21 laboratories from 21 countries submitted data for N meningitidis (5877 total cases). All countries and territories had experienced a significant and sustained reduction in invasive diseases due to S pneumoniae, H influenzae, and N meningitidis in early 2020 (Jan 1 to May 31, 2020), coinciding with the introduction of COVID-19 containment measures in each country. By contrast, no significant changes in the incidence of invasive S agalactiae infections were observed. Similar trends were observed across most countries and territories despite differing stringency in COVID-19 control policies. The incidence of reported S pneumoniae infections decreased by 68% at 4 weeks (incidence rate ratio 0·32 [95% CI 0·27-0·37]) and 82% at 8 weeks (0·18 [0·14-0·23]) following the week in which significant changes in population movements were recorded. INTERPRETATION: The introduction of COVID-19 containment policies and public information campaigns likely reduced transmission of S pneumoniae, H influenzae, and N meningitidis, leading to a significant reduction in life-threatening invasive diseases in many countries worldwide. FUNDING: Wellcome Trust (UK), Robert Koch Institute (Germany), Federal Ministry of Health (Germany), Pfizer, Merck, Health Protection Surveillance Centre (Ireland), SpID-Net project (Ireland), European Centre for Disease Prevention and Control (European Union), Horizon 2020 (European Commission), Ministry of Health (Poland), National Programme of Antibiotic Protection (Poland), Ministry of Science and Higher Education (Poland), Agencia de Salut Pública de Catalunya (Spain), Sant Joan de Deu Foundation (Spain), Knut and Alice Wallenberg Foundation (Sweden), Swedish Research Council (Sweden), Region Stockholm (Sweden), Federal Office of Public Health of Switzerland (Switzerland), and French Public Health Agency (France).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2589-7500(21)00077-7

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cumulative number of invasive disease cases collected by Invasive Respiratory Infection Surveillance laboratories each week from Jan 1, 2018, to May 31, 2020 Data for Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis were obtained from Belgium, Brazil, Canada (S pneumoniae only), China (S pneumoniae and H influenzae only), Czech Republic, Denmark, England, Finland, France, Germany, Hong Kong, Iceland, Ireland, Israel (S pneumoniae and H influenzae only), Luxembourg, the Netherlands, New Zealand, Northern Ireland, Poland, Scotland, South Africa, South Korea (S pneumoniae and H influenzae only), Spain (S pneumoniae and N meningitidis only), Sweden, Switzerland (S pneumoniae and H influenzae only), and Wales. Data for Streptococcus agalactiae were obtained from Denmark, England, Finland, Germany, Iceland, Ireland, Israel, the Netherlands, and Poland. The grey dotted line (on week 11) shows when WHO officially declared the COVID-19 pandemic. ISO=International Organization for Standardization.
Figure 1 Cumulative number of invasive disease cases collected by Invasive Respiratory Infection Surveillance laboratories each week from Jan 1, 2018, to May 31, 2020 Data for Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis were obtained from Belgium, Brazil, Canada (S pneumoniae only), China (S pneumoniae and H influenzae only), Czech Republic, Denmark, England, Finland, France, Germany, Hong Kong, Iceland, Ireland, Israel (S pneumoniae and H influenzae only), Luxembourg, the Netherlands, New Zealand, Northern Ireland, Poland, Scotland, South Africa, South Korea (S pneumoniae and H influenzae only), Spain (S pneumoniae and N meningitidis only), Sweden, Switzerland (S pneumoniae and H influenzae only), and Wales. Data for Streptococcus agalactiae were obtained from Denmark, England, Finland, Germany, Iceland, Ireland, Israel, the Netherlands, and Poland. The grey dotted line (on week 11) shows when WHO officially declared the COVID-19 pandemic. ISO=International Organization for Standardization.CC BY · PubMed Central
Figure 2 Annual invasive Streptococcus pneumoniae cases submitted to Invasive Respiratory Infection Surveillance laboratories in 26 countries and territories from Jan 1, 2018, to May 31, 2020 Coloured bars represent the mean weekly Oxford COVID-19 Government Response Tracker (OxCGRT) stringency index values on a scale from 0 to 100, with larger (darker) values indicating that higher stringency measures were enacted within a country. Data for South Korea were submitted from two surveillance networks, one of which started invasive disease surveillance in September, 2018, so data presented here for that hospital are only from September, 2018, onwards, whereas the data from the other hospital are from January, 2018, onwards. ISO=International Organization for Standardization.
Figure 2 Annual invasive Streptococcus pneumoniae cases submitted to Invasive Respiratory Infection Surveillance laboratories in 26 countries and territories from Jan 1, 2018, to May 31, 2020 Coloured bars represent the mean weekly Oxford COVID-19 Government Response Tracker (OxCGRT) stringency index values on a scale from 0 to 100, with larger (darker) values indicating that higher stringency measures were enacted within a country. Data for South Korea were submitted from two surveillance networks, one of which started invasive disease surveillance in September, 2018, so data presented here for that hospital are only from September, 2018, onwards, whereas the data from the other hospital are from January, 2018, onwards. ISO=International Organization for Standardization.CC BY · PubMed Central
Figure 3 Estimated country-specific incidence rate ratios for invasive disease due to Streptococcus pneumoniae following interruptions in population mobility during the COVID-19 pandemic Estimated country-specific incidence rate ratios calculated using an interrupted time series model that allows for a step (A) or slope (B) reduction in invasive disease. Estimated country-specific incidence rate ratios after 4 weeks (C) or 8 weeks (D) from the point at which national mobility was significantly interrupted (appendix p 4).
Figure 3 Estimated country-specific incidence rate ratios for invasive disease due to Streptococcus pneumoniae following interruptions in population mobility during the COVID-19 pandemic Estimated country-specific incidence rate ratios calculated using an interrupted time series model that allows for a step (A) or slope (B) reduction in invasive disease. Estimated country-specific incidence rate ratios after 4 weeks (C) or 8 weeks (D) from the point at which national mobility was significantly interrupted (appendix p 4).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 1

  1. 2019, Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper–February 2019, Wkly Epidemiol Rec, 94, 85

Cited by

See all 555

Metadata

Authors
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., Brandileone, M.-C. C., Broughton, K., Campbell, R., Cao, B., Casanova, C., Choi, E. H., Chu, Y. W., Clark, S. A., Claus, H., Coelho, J., Corcoran, M., Cottrell, S., Cunney, R. J., Dalby, T., Davies, H., de Gouveia, L., Deghmane, A.-E., Demczuk, W., Desmet, S., Drew, R. J., du Plessis, M., Erlendsdottir, H., Fry, N. K., Fuursted, K., Gray, S. J., Henriques-Normark, B., Hale, T., Hilty, M., Hoffmann, S., Humphreys, H., Ip, M., Jacobsson, S., Johnston, J., Kozakova, J., Kristinsson, K. G., Krizova, P., Kuch, A., Ladhani, S. N., Lâm, T.-T., Lebedova, V., Lindholm, L., Litt, D. J., Martin, I., Martiny, D., Mattheus, W., McElligott, M., Meehan, M., Meiring, S., Mölling, P., Morfeldt, E., Morgan, J., Mulhall, R. M., Muñoz-Almagro, C., Murdoch, D. R., Murphy, J., Musilek, M., Mzabi, A., Perez-Argüello, A., Perrin, M., Perry, M., Redin, A., Roberts, R., Roberts, M., Rokney, A., Ron, M., Scott, K. J., Sheppard, C. L., Siira, L., Skoczyńska, A., Sloan, M., Slotved, H.-C., Smith, A. J., Song, J. Y., Taha, M.-K., Toropainen, M., Tsang, D., Vainio, A., van Sorge, N. M., Varon, E., Vlach, J., Vogel, U., Vohrnova, S., von Gottberg, A., Zanella, R. C., & Zhou, F.
Affiliations
  • University of Oxford (GB)
  • Trinity College Dublin (IE)
  • Beaumont Hospital (IE)
  • Manchester Royal Infirmary (GB)
  • Public Health England (GB)
  • Public Health Agency (GB)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • University of Bern (CH)
  • Seoul National University (KR)
  • Department of Health (CN)
  • University of Würzburg (DE)
  • Royal College of Surgeons in Ireland (IE)
  • Public Health Wales (GB)
  • Statens Serum Institut (DK)
  • New Zealand Institute for Public Health and Forensic Science (NZ)
  • Institut Pasteur (FR)
  • Public Health Agency of Canada (CA)
  • Universitair Ziekenhuis Leuven (BE)
  • Chinese University of Hong Kong (HK)
  • Örebro University (SE)
  • National University Hospital of Iceland (IS)
  • Narodowy Instytut Leków (PL)
  • National Institute of Public Health (CZ)
  • Finnish Institute for Health and Welfare (FI)
  • University of Mons (BE)
  • Sciensano (Belgium) (BE)
  • National Health Laboratory Service (ZA)
  • Public Health Agency of Sweden (SE)
  • University of Otago (NZ)
  • Laboratoire National de Santé (LU)
  • Hospital Sant Joan de Déu Barcelona (ES)
  • Israel Ministry of Health (IL)
  • Korea University (KR)
  • Hôpital Intercommunal de Créteil (FR)
  • Instituto Adolfo Lutz (BR)
Corresponding author
Brueggemann, Angela B
Venue
The Lancet Digital Health
Publisher
Elsevier BV
Published
2021-06
Volume
3
Issue
6
Pages
e360-e370
ISSN
2589-7500 (ISSN-L)
OpenAlex
W3164937600
Cited by
546
References
29
Citations by year
2026: 56 · 2025: 120 · 2024: 103 · 2023: 130 · 2022: 94 · 2021: 42
FWCI
66.45
Type
journal article
Language
en
Update notices
erratum (2021-07-01)
Open access
Licence
Locations
  • The Lancet Digital Health (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Opin vísindi (Opin vísindi) (submittedVersion, cc-by-nc-sa)
  • Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Otago University Research Archive (University of Otago) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Opin vísindi (Opin vísindi) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Hirsla (Landspítali University Hospital) (submittedVersion, cc-by)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion, cc-by)
  • RWTH Publications (RWTH Aachen)
Funders
  • Royal College of Surgeons in Ireland
  • Sanofi Pasteur
  • Public Health England
  • Pfizer
  • Vetenskapsrådet
  • Merck Sharp and Dohme
  • Ministerstwo Edukacji i Nauki
  • Wellcome Trust (206394/Z/17/Z, 218205/Z/19/Z)
  • Statens Serum Institut
  • Merck (1369-237)
  • Knut och Alice Wallenbergs Stiftelse
  • Roche (630133, WO 2013/020090 A3)
  • St. George's, University of London
  • Ministry of Health
  • Bundesamt für Gesundheit
  • Astellas Pharma US
  • ABB
  • GlaxoSmithKline
  • Bundesministerium für Gesundheit (1369-235)
Topics
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, invasive bacterial infection, COVID-19 containment measures, incidence trends, meningitis, Streptococcus agalactiae, respiratory infection surveillance, community mobility, respiratory droplet transmission
MeSH terms
COVID-19, Bacterial Infections, Haemophilus influenzae, Humans, Neisseria meningitidis, Population Surveillance, Prospective Studies, Respiratory Tract Infections, Streptococcus agalactiae, Streptococcus pneumoniae, Public Health Practice, Incidence, Interrupted Time Series Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. https://app.cochat.ai/papers/10.1016/s2589-7500(21)00077-7
The paper
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., Brandileone, M.-C. C., Broughton, K., Campbell, R., Cao, B., Casanova, C., Choi, E. H., Chu, Y. W., Clark, S. A., Claus, H., . . . Zhou, F. (2021). Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(21)00077-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.